Advice Concerning the Addition of Certain Pharmaceutical Products and Chemical Intermediates to the Pharmaceutical Appendix to the Harmonized Tariff Schedule of the United States, 34643-34644 [E6-9455]

Download as PDF Federal Register / Vol. 71, No. 115 / Thursday, June 15, 2006 / Notices Total Estimated Burden Hours: 5,000. Status: Extension of a currently approved collection. Authority: Section 3507 of the Paperwork Reduction Act of 1995, 44 U.S.C. 35, as amended. Dated: June 8, 2006. Lillian L. Deitzer, Departmental Paperwork Reduction Act Officer, Office of the Chief Information Officer. [FR Doc. E6–9322 Filed 6–14–06; 8:45 am] BILLING CODE 4210–67–P Dated: June 8, 2006. June Bailey, Lewistown Field Manager. [FR Doc. E6–9340 Filed 6–14–06; 8:45 am] DEPARTMENT OF THE INTERIOR Bureau of Land Management [MT–060–01–1020–PG] Notice of Public Meeting; Central Montana Resource Advisory Council AGENCY: Administrative details. All RAC meetings are open to the public. The public may present written comments to the RAC. Each formal RAC meeting will also have time allocated for hearing public comments. Depending on the number of persons wishing to comment and time available, the time for individual oral comments may be limited. FOR FURTHER INFORMATON CONTACT: June Bailey, Lewistown Field Manager, Lewistown Field Office, P.O. Box 1160, Lewistown, Montana 59457 or at 406– 538–1900. Bureau of Land Management, Interior. Notice of public meeting. BILLING CODE 4310–$$–P DEPARTMENT OF THE INTERIOR Bureau of Reclamation jlentini on PROD1PC65 with NOTICES ACTION: SUMMARY: In accordance with the Federal Land Policy and Management Act and the Federal Advisory Committee Act of 1972, the U.S. Department of the Interior, Bureau of Land Management (BLM) Central Montana Resource Advisory Council (RAC) will meet as indicated below. DATES: The meeting will be held July 12 & 13, 2006, at the Cottonwood Inn, in Glasgow, Montana. The July 12 session will begin at 8 a.m. and consist of a field trip to public lands in the Glasgow area. This tour is scheduled to adjourn at 5 p.m. The July 13 meeting will begin at 8 a.m. with a 30-minute public comment period. This meeting is scheduled to adjourn at 3 p.m. SUPPLEMENTARY INFORMATION: This 15member council advises the Secretary of the Interior on a variety of management issues associated with public land management in Montana. At this meeting the council will discuss/act upon: The minutes of their proceeding meeting; A discussion of the American Prairie Foundation project; A briefing concerning the upcoming Malta Resource Management Plan; A review of Revised Statute—2477, An update about the Bowdoin Gas Field; A discussion of proposed revisions to grazing regulations; A briefing about transportation planning; and VerDate Aug<31>2005 15:47 Jun 14, 2006 Jkt 208001 California Bay-Delta Public Advisory Committee Public Meeting Bureau of Reclamation, Interior. ACTION: Notice of meeting. AGENCY: SUMMARY: In accordance with the Federal Advisory Committee Act, the California Bay-Delta Public Advisory Committee (Committee) will meet on July 13, 2006. The agenda for the Committee meeting will include discussions with State and Federal agency representatives on the 10-Year Action Plan, Subcommittee structure, the Bay-Delta Conservation Plan and its relationship to the Delta Regional Ecosystem Restoration Plan, the Delta Vision, end of Stage 1 decisions, and recommendations on implementing agency Program Plans. DATES: The meeting will be held on Thursday, July 13, 2006, from 9 a.m. to 4 p.m. If reasonable accommodation is needed due to a disability, please contact Colleen Kirtlan at (916) 445– 5511 or TDD (800) 735–2929 at least 1 week prior to the meeting. ADDRESSES: These meetings will be held at the John E. Moss Federal Building located at 650 Capitol Mall, 5th Floor, Sacramento, California. FOR FURTHER INFORMATION CONTACT: Diane Buzzard, U.S. Bureau of Reclamation, at 916–978–5022 or Julie Alvis, California Bay-Delta Authority, at 916–445–5551. SUPPLEMENTARY INFORMATION: The Committee was established to provide advice and recommendations to the Secretary of the Interior on PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 34643 implementation of the CALFED BayDelta Program. The Committee makes recommendations on annual priorities, integration of the eleven Program elements, and overall balancing of the four Program objectives of ecosystem restoration, water quality, levee system integrity, and water supply reliability. The Program is a consortium of State and Federal agencies with the mission to develop and implement a long-term comprehensive plan that will restore ecological health and improve water management for beneficial uses of the San Francisco/Sacramento and San Joaquin Bay Delta. Committee agendas and meeting materials will be available prior to all meetings on the California Bay-Delta Authority Web site at https:// calwater.ca.gov and at the meetings. These meetings are open to the public. Oral comments will be accepted from members of the public at each meeting and will be limited to 3–5 minutes. (Authority: The Committee was established pursuant to the Department of the Interior’s authority to implement the Water Supply,Rreliability, and Environmental Improvement Act, Pub. L. 108–361; the Fish and Wildlife Coordination Act, 16 U.S.C. 661 et seq.; the Endangered Species Act, 16 U.S.C. 1531 et seq.; and the Reclamation Act of 1902, 43 U.S.C. 391 et seq., and the acts amendatory thereof or supplementary thereto, all collectively referred to as the Federal Reclamation laws, and in particular, the Central Valley Project Improvement Act, 34 U.S.C. 3401.) Dated: June 6, 2006. Allan Oto, Special Projects Officer, Mid-Pacific Region, U.S. Bureau of Reclamation. [FR Doc. 06–5431 Filed 6–14–06; 8:45 am] BILLING CODE 4310–MN–M INTERNATIONAL TRADE COMMISSION [Investigation No. 332–476] Advice Concerning the Addition of Certain Pharmaceutical Products and Chemical Intermediates to the Pharmaceutical Appendix to the Harmonized Tariff Schedule of the United States United States International Trade Commission. ACTION: Institution of investigation. AGENCY: DATES: Effective Date: June 12, 2006. SUMMARY: Following receipt of a request on May 25, 2006, from the United States Trade Representative (USTR), the Commission instituted Investigation No. 332–476, Advice Concerning the Addition of Certain Pharmaceutical E:\FR\FM\15JNN1.SGM 15JNN1 34644 Federal Register / Vol. 71, No. 115 / Thursday, June 15, 2006 / Notices Products and Chemical Intermediates to the Pharmaceutical Appendix to the Harmonized Tariff Schedule of the United States, under section 332(g) of the Tariff Act of 1930 (19 U.S.C. 1332(g)). jlentini on PROD1PC65 with NOTICES FOR FURTHER INFORMATION CONTACT: Information specific to these investigations may be obtained from Philip Stone, Project Leader (202–205– 3424; philip.stone@usitc.gov), Office of Industries, United States International Trade Commission, Washington, DC, 20436. For information on the legal aspects of these investigations, contact William Gearhart of the Office of the General Counsel (202–205–3091; william.gearhart@usitc.gov). General information concerning the Commission may also be obtained by accessing its Internet server (https://www.usitc.gov). Background: As one part of the market access tariff results of the Uruguay Round negotiations, the United States and 21 other countries agreed to reciprocal elimination of duties on certain pharmaceutical products and chemical intermediates used primarily for the production of pharmaceuticals. In the Uruguay Round Agreement Act (URAA), Congress authorized the President to grant duty-free treatment to new pharmaceutical products and chemical intermediates. One of the requirements set out in the URAA is that the President ‘‘obtain advice regarding the proposed action’’ from the Commission. Pursuant to section 115 of the URAA and section 332(g) of the Tariff Act of 1930, the USTR requests that the Commission provide advice in the form of additional information on the pharmaceutical products and chemical intermediates currently under consideration. The USTR specifically requests (1) a summary description of the products contained in the existing Pharmaceutical Appendix and the modifications made to that Appendix; (2) an explanation of the relationship between the various elements in the Appendix and the Harmonized Tariff Schedule of the United States; and (3) an estimate of the current U.S. imports and, where possible, current U.S. exports of the products included in the existing Pharmaceutical Appendix and the proposed additions to the Appendix. A list of the proposed additions to the Pharmaceutical Appendix is available on the Commission’s Web site at https://www.usitc.gov/ind_econ_ana/ combined_tables_pharma_332.pdf. The Commission expects to provide its report to the USTR by September 1, 2006. Written Submissions: The Commission does not plan to hold a VerDate Aug<31>2005 15:47 Jun 14, 2006 Jkt 208001 public hearing in connection with preparation of this report. However, interested parties are invited to submit written statements containing pertinent data such as levels of exports and imports for the items included in this investigation. All submissions should be addressed to the Secretary, United States International Trade Commission, 500 E Street, SW., Washington, DC 20436, and should be received no later than 5:15 p.m. EDT on June 21, 2006. All written submissions must conform with the provisions of section 201.8 of the Commission’s Rules of Practice and Procedure (19 CFR 201.8). Section 201.8 of the rules requires that a signed original (or a copy designated as an original) and fourteen (14) copies of each document be filed. In the event that confidential treatment of the document is requested, at least four (4) additional copies must be filed, in which the confidential information must be deleted (see the following paragraph for further information regarding confidential business information). The Commission’s rules do not authorize filing submissions with the Secretary by facsimile or electronic means, except to the extent permitted by section 201.8 of the rules (see Handbook for Electronic Filing Procedures, https:// www.usitc.gov/secretary/ fed_reg_notices/rules/documents/ handbook_on_electronic_filing.pdf). Any submissions that contain confidential business information must also conform with the requirements of section 201.6 of the Commission’s Rules of Practice and Procedure (19 CFR 201.6). Section 201.6 of the rules requires that the cover of the document and the individual pages be clearly marked as to whether they are the ‘‘confidential’’ or ‘‘nonconfidential’’ version, and that the confidential business information be clearly identified by means of brackets. All written submissions, except for confidential business information, will be made available in the Office of the Secretary to the Commission for inspection by interested parties. In his request letter, the USTR stated that he intends to make the Commission’s report available to the public in its entirety, and asked that the Commission not include any confidential business or national security confidential information in the report. The report that the Commission sends to the USTR will not contain any such information. Any confidential business information received by the Commission in this investigation and used in preparing the report will not be published in a manner that would PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 reveal the operations of the firm supplying the information. The public record for these investigations may be viewed on the Commission’s electronic docket (EDIS) at https://www.usitc.gov/secretary/ edis.htm. Hearing-impaired individuals are advised that information on this matter can be obtained by contacting our TDD terminal on 202–205–1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at 202–205–2000. By order of the Commission. Issued: June 13, 2006. Marilyn R. Abbott, Secretary to the Commission. [FR Doc. E6–9455 Filed 6–14–06; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—ASTM International— Standards Notice is hereby given that, on May 24, 2006, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), ASTM International—Standards (‘‘ASTM’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing additions or changes to its standards development activities. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, ASTM has provided an updated list of current, ongoing ASTM standards activities originating between February 2006 and May 2006, designated as Work Items. A complete listing of ASTM Work Items, along with a brief description of each, is available at https://www.astm.org. On September 15, 2004, ASTM filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on November 10, 2004 (69 FR 65226). The last notification was filed with the Department on February 17, 2006. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on April 12, 2006 (71 FR 18769). E:\FR\FM\15JNN1.SGM 15JNN1

Agencies

[Federal Register Volume 71, Number 115 (Thursday, June 15, 2006)]
[Notices]
[Pages 34643-34644]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-9455]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 332-476]


Advice Concerning the Addition of Certain Pharmaceutical Products 
and Chemical Intermediates to the Pharmaceutical Appendix to the 
Harmonized Tariff Schedule of the United States

AGENCY: United States International Trade Commission.

ACTION: Institution of investigation.

-----------------------------------------------------------------------

DATES: Effective Date: June 12, 2006.
SUMMARY: Following receipt of a request on May 25, 2006, from the 
United States Trade Representative (USTR), the Commission instituted 
Investigation No. 332-476, Advice Concerning the Addition of Certain 
Pharmaceutical

[[Page 34644]]

Products and Chemical Intermediates to the Pharmaceutical Appendix to 
the Harmonized Tariff Schedule of the United States, under section 
332(g) of the Tariff Act of 1930 (19 U.S.C. 1332(g)).

FOR FURTHER INFORMATION CONTACT: Information specific to these 
investigations may be obtained from Philip Stone, Project Leader (202-
205-3424; philip.stone@usitc.gov), Office of Industries, United States 
International Trade Commission, Washington, DC, 20436. For information 
on the legal aspects of these investigations, contact William Gearhart 
of the Office of the General Counsel (202-205-3091; 
william.gearhart@usitc.gov). General information concerning the 
Commission may also be obtained by accessing its Internet server 
(https://www.usitc.gov).
    Background: As one part of the market access tariff results of the 
Uruguay Round negotiations, the United States and 21 other countries 
agreed to reciprocal elimination of duties on certain pharmaceutical 
products and chemical intermediates used primarily for the production 
of pharmaceuticals. In the Uruguay Round Agreement Act (URAA), Congress 
authorized the President to grant duty-free treatment to new 
pharmaceutical products and chemical intermediates. One of the 
requirements set out in the URAA is that the President ``obtain advice 
regarding the proposed action'' from the Commission. Pursuant to 
section 115 of the URAA and section 332(g) of the Tariff Act of 1930, 
the USTR requests that the Commission provide advice in the form of 
additional information on the pharmaceutical products and chemical 
intermediates currently under consideration. The USTR specifically 
requests (1) a summary description of the products contained in the 
existing Pharmaceutical Appendix and the modifications made to that 
Appendix; (2) an explanation of the relationship between the various 
elements in the Appendix and the Harmonized Tariff Schedule of the 
United States; and (3) an estimate of the current U.S. imports and, 
where possible, current U.S. exports of the products included in the 
existing Pharmaceutical Appendix and the proposed additions to the 
Appendix.
    A list of the proposed additions to the Pharmaceutical Appendix is 
available on the Commission's Web site at https://www.usitc.gov/ind_
econ_ana/combined_tables_pharma_332.pdf. The Commission expects to 
provide its report to the USTR by September 1, 2006.
    Written Submissions: The Commission does not plan to hold a public 
hearing in connection with preparation of this report. However, 
interested parties are invited to submit written statements containing 
pertinent data such as levels of exports and imports for the items 
included in this investigation. All submissions should be addressed to 
the Secretary, United States International Trade Commission, 500 E 
Street, SW., Washington, DC 20436, and should be received no later than 
5:15 p.m. EDT on June 21, 2006. All written submissions must conform 
with the provisions of section 201.8 of the Commission's
    Rules of Practice and Procedure (19 CFR 201.8). Section 201.8 of 
the rules requires that a signed original (or a copy designated as an 
original) and fourteen (14) copies of each document be filed. In the 
event that confidential treatment of the document is requested, at 
least four (4) additional copies must be filed, in which the 
confidential information must be deleted (see the following paragraph 
for further information regarding confidential business information). 
The Commission's rules do not authorize filing submissions with the 
Secretary by facsimile or electronic means, except to the extent 
permitted by section 201.8 of the rules (see Handbook for Electronic 
Filing Procedures, https://www.usitc.gov/secretary/fed_reg_notices/
rules/documents/handbook_on_electronic_filing.pdf).
    Any submissions that contain confidential business information must 
also conform with the requirements of section 201.6 of the Commission's 
Rules of Practice and Procedure (19 CFR 201.6). Section 201.6 of the 
rules requires that the cover of the document and the individual pages 
be clearly marked as to whether they are the ``confidential'' or 
``nonconfidential'' version, and that the confidential business 
information be clearly identified by means of brackets. All written 
submissions, except for confidential business information, will be made 
available in the Office of the Secretary to the Commission for 
inspection by interested parties.
    In his request letter, the USTR stated that he intends to make the 
Commission's report available to the public in its entirety, and asked 
that the Commission not include any confidential business or national 
security confidential information in the report. The report that the 
Commission sends to the USTR will not contain any such information. Any 
confidential business information received by the Commission in this 
investigation and used in preparing the report will not be published in 
a manner that would reveal the operations of the firm supplying the 
information.
    The public record for these investigations may be viewed on the 
Commission's electronic docket (EDIS) at https://www.usitc.gov/
secretary/edis.htm. Hearing-impaired individuals are advised that 
information on this matter can be obtained by contacting our TDD 
terminal on 202-205-1810. Persons with mobility impairments who will 
need special assistance in gaining access to the Commission should 
contact the Office of the Secretary at 202-205-2000.

    By order of the Commission.

    Issued: June 13, 2006.
Marilyn R. Abbott,
Secretary to the Commission.
 [FR Doc. E6-9455 Filed 6-14-06; 8:45 am]
BILLING CODE 7020-02-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.